Applicant, as named in the Orange Book

Glaxosmithkline

GSK plc · NYSE: GSK

Company and ticker: cliffwatch mapping, checked against SEC EDGAR · SEC filings

Next listed expiry: Anoro Ellipta on 29 Nov 2030. 7 products with live protection, 12 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Anoro Ellipta NDA 203975 umeclidinium bromide; vilanterol trifenatate	umeclidinium bromide; vilanterol trifenatate	29 Nov 2030 patent	patent
Trelegy Ellipta NDA 209482 · 2 strengths fluticasone furoate; umeclidinium bromide; vilanterol trifenatate	fluticasone furoate; umeclidinium bromide; vilanterol trifenatate	11 Apr 2031 patent	patent
Utebzi NDA 215960 tebipenem pivoxil hydrobromide	tebipenem pivoxil hydrobromide	6 Feb 2038 patent	patent
Zejula NDA 214876 · 3 strengths niraparib tosylate	niraparib tosylate	25 Jan 2039 patent	patent
Brexafemme NDA 214900 ibrexafungerp citrate	ibrexafungerp citrate	10 Jun 2039 patent, carve-out possible	patent, carve-out possible
Ojjaara NDA 216873 · 3 strengths momelotinib dihydrochloride	momelotinib dihydrochloride	2 Dec 2040 patent, carve-out possible	patent, carve-out possible
Blujepa NDA 218230 gepotidacin mesylate	gepotidacin mesylate	13 Dec 2042 patent	patent

Recent events

Thorazine · Generic approved · ANDA 216678, Rubicon ResearchApproved 10 Oct 2025Detected 25 Oct 2026
Bactroban · Generic approved · ANDA 218361, Zydus LifesciencesApproved 29 Sep 2026Detected 25 Oct 2026
Thorazine · Generic approved · ANDA 216092, MsnApproved 26 Jan 2026Detected 25 Oct 2026

Products without listed protection (12)

Drug	Ingredient	Earliest generic entry	Basis
Arnuity Ellipta NDA 205625 · 3 strengths fluticasone furoate	fluticasone furoate	open now no listed protection	no listed protection
Imitrex NDA 020626 · 2 strengths sumatriptan	sumatriptan	open now no listed protection	no listed protection
Imitrex NDA 020132 · 3 strengths sumatriptan succinate	sumatriptan succinate	open now no listed protection	no listed protection
Imitrex Statdose (Autoinjector) NDA 020080 · 2 strengths sumatriptan succinate	sumatriptan succinate	open now no listed protection	no listed protection
Krintafel NDA 210795 tafenoquine succinate	tafenoquine succinate	open now no listed protection	no listed protection
Malarone NDA 021078 atovaquone; proguanil hydrochloride	atovaquone; proguanil hydrochloride	open now no listed protection	no listed protection
Malarone Pediatric NDA 021078 atovaquone; proguanil hydrochloride	atovaquone; proguanil hydrochloride	open now no listed protection	no listed protection
Relenza NDA 021036 zanamivir	zanamivir	open now no listed protection	no listed protection
Serevent NDA 020692 salmeterol xinafoate	salmeterol xinafoate	open now no listed protection	no listed protection
Valtrex NDA 020487 · 2 strengths valacyclovir hydrochloride	valacyclovir hydrochloride	open now no listed protection	no listed protection
Ventolin Hfa NDA 020983 albuterol sulfate	albuterol sulfate	open now no listed protection	no listed protection
Wellbutrin Sr NDA 020358 · 3 strengths bupropion hydrochloride	bupropion hydrochloride	open now no listed protection	no listed protection